Optimi Health Corp.
OPTH
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic·Mkt cap $15.4M
$4.78
▲ +1.60%
P/E
-6.49
Mkt Cap
$15.4M
52-Wk Range
$4.00–$6.40
52-Week Range
$4.00 - $6.40
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 14.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Above-average volatility (beta 1.6).
Growth
Strong growth ahead
Value
Deep value opportunity - significant discount to sector peers
Momentum
Stable
+2.9% over 3m
Quality
Mixed
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying OPTH right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Sep 7, 2026
AUG 14, 2026
Reported EPS of -$0.40 vs -$0.26 consensus (-53.9% surprise). Revenue of $98.7K vs $154.9K expected (-36.3%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-53.9%
Revenue trend · last 2Q
—
-50%
Q1 26
Q3 26
$0
$98.7K
Margins · last 2Q
Profit
-1715.0%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How OPTH stacks vs Drug Manufacturers - Specialty & Generic
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.